Answer
No. It is a prolonged-release formulation and is not intended for rapidly developing breakthrough pain.
Sources for this answer
- Targinact 5 mg/2.5 mg prolonged-release tablets — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.